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Abstract:  Addictive drugs, such as opioids, ethanol, cocaine, amphetamine, and phencyclidine (PCP), affect many   
functions of the nervous system and peripheral organs, resulting in severe health problems. G protein-activated inwardly 
rectifying K
+ (GIRK, Kir3) channels play an important role in regulating neuronal excitability through activation of   
various Gi/o protein-coupled receptors including opioid and CB1 cannabinoid receptors. Furthermore, the channels are  
directly activated by ethanol and inhibited by cocaine at toxic levels, but not affected by methylphenidate, methampheta-
mine, and 3,4-methylenedioxymethamphetamine (MDMA) at toxic levels. The primary pharmacological action of PCP is 
blockade of N-methyl-D-aspartate (NMDA) receptor channels that are associated with its psychotomimetic effects. PCP 
also interacts with several receptors and channels at relatively high concentrations. However, the molecular mechanisms 
underlying the various effects of PCP remain to be clarified. Here, we investigated the effects of PCP on GIRK channels 
using the Xenopus oocyte expression system. PCP weakly but significantly inhibited GIRK channels at micromolar   
concentrations, but not Kir1.1 and Kir2.1 channels. The PCP concentrations effective in inhibiting GIRK channels overlap 
clinically relevant brain concentrations in severe intoxication. The results suggest that partial inhibition of GIRK channels 
by PCP may contribute to some of the toxic effects after overdose. 
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INTRODUCTION 
  G protein-activated inwardly rectifying K
+ (GIRK) chan-
nels (also known as Kir3 channels) are members of a family 
of inwardly rectifying K
+ (Kir) channels that includes seven 
subfamilies [1]. Four GIRK channel subunits have been 
identified in mammals [1]. Neuronal GIRK channels are 
predominantly heteromultimers composed of GIRK1 and 
GIRK2 subunits in most brain regions or homomultimers 
composed of GIRK2 subunits in the substantia nigra, 
whereas atrial GIRK channels are heteromultimers com-
posed of GIRK1 and GIRK4 subunits [2]. GIRK channels 
play an important role in the inhibitory regulation of neu-
ronal excitability in most brain regions and heart rate through 
activation of various Gi/o protein-coupled receptors, such as 
opioid, CB1 cannabinoid, and D2 dopamine receptors [2]. 
Furthermore, the channels are modulated by various psy-
choactive agents, such as ethanol, antipsychotics, antidepres-
sants, anesthetics, and hormones [2-11]. Recently, we dem-
onstrated that cocaine at toxic levels inhibited GIRK chan-
nels expressed in Xenopus oocytes. In contrast, methylpheni-
date, methamphetamine, and 3,4-methylenedioxymetham-
phetamine (MDMA) at toxic levels had little effect on GIRK 
channels, although these drugs at higher concentrations in-
hibited the channels to a lesser extent than cocaine [12]. 
 
*Address correspondence to this author at the Department of Project Pro-
grams, Center for Bioresource-based Researches, Brain Research Institute, 
Niigata University, 1-757 Asahimachi, Chuo-ku, Niigata, Niigata 951-8585, 
Japan; Tel: +81-25-227-0646; Fax: +81-25-227-0818; 
E-mail: torukoba@bri.niigata-u.ac.jp 
  Phencyclidine (PCP) has been used as a drug of abuse, 
although it was originally developed as a general anesthetic 
in the 1950s [13, 14]. The primary pharmacological action of 
PCP is blockade of N-methyl-D-aspartate (NMDA) receptor 
channels that are associated with its psychotomimetic effects 
[13, 14]. PCP at relatively high concentrations interacts with 
several receptors and channels, namely, , μ-opioid, nico-
tinic- and muscarinic-acetylcholine receptors, voltage-gated 
K
+, Na
+ and Ca
2+ channels, and adenosine triphosphate 
(ATP)-sensitive K
+ channels [14, 15, 16]. However, the mo-
lecular mechanisms underlying the various effects of PCP 
have not yet been sufficiently clarified. In the present study, 
we investigated the effects of PCP on GIRK channels   
and other Kir channels using the Xenopus oocyte expression 
system. 
METHODS 
 For  Xenopus oocyte experiments [4, 5], Xenopus laevis 
oocytes were injected with mRNA for GIRK1/GIRK2 or 
GIRK1/GIRK4 combinations, GIRK2, Kir1.1, or Kir2.1. The 
oocytes were incubated at 19°C in Barth's solution and defol-
liculated after collagenase treatment. Whole-cell currents of 
the oocytes were recorded with a conventional two-electrode 
voltage clamp. Oocytes were superfused with a high-
potassium solution containing 96 mM K
+. The membrane 
potential was held at 70 mV. The values obtained are   
expressed as mean ± SEM, with n indicating the number of 
oocytes tested. PCP was generously provided by Shionogi 
Pharmaceutical Co. Ltd. (Osaka, Japan). Inhibition of G Protein-Activated Inwardly Rectifying K
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RESULTS 
 In  Xenopus oocytes injected with GIRK1 and GIRK2 
mRNA, PCP reversibly reduced basal GIRK inward currents 
(Fig. (1A)). Similar results were observed in oocytes injected 
with either GIRK1 and GIRK4 mRNA or GIRK2 mRNA. 
However, in oocytes expressing either Kir1.1 or Kir2.1 
channels, PCP caused no significant response even at 100 
μM (less than 5 nA, n = 4, Fig. (1A)). Additionally, in unin-
jected oocytes, 100 μM PCP and 3 mM Ba
2+, a Kir channel 
blocker, caused no significant response (Fig. (1A)). The results 
suggest that PCP inhibits GIRK channels. The inhibition by 
PCP was concentration-dependent (n = 4, Fig. (1B)). 
DISCUSSION 
  We demonstrated that PCP at micromolar concentrations 
inhibited brain-type GIRK1/2 and GIRK2 channels and 
atrial-type GIRK1/4 channels expressed in Xenopus oocytes. 
At 100 μM or less, the inhibitory effects of PCP were more 
potent than those of cocaine, methylphenidate, metham-
phetamine, and MDMA (Fig. (2)). In other Kir channel sub-
families, Kir1.1 and Kir2.1 channels were insensitive to 
these psychostimulants [12] and PCP, whereas PCP inhibited 
cardiac ATP-sensitive K
+ channels, which comprise four 
pore-forming Kir6 subunits and four regulatory sulfonylurea 
receptor subunits, with an IC50 value of approximately 20 
μM [16]. Further studies using GIRK/Kir1.1 and GIRK/ 
Kir2.1 chimeric channels and mutant GIRK channels   
may clarify the critical sites mediating the effects of PCP on 
GIRK channels. 
  The use of PCP as a drug of abuse is an important medi-
cal problem. Serum PCP concentrations after overdose were 
reported to reach up to approximately 10 μM in some post-
mortem cases, up to 45 μM in one massive overdose case 
[17], and up to approximately 3.3 μM in some nonfatal cases 
[18], although serum concentrations in most intoxication 
cases ranged widely from nanomolar to low micromolar con-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Inhibitory effects of PCP on GIRK channels expressed in Xenopus oocytes. (A) Top, in an oocyte injected with GIRK1 and GIRK2 
mRNA, current responses to 10 μM and 100 μM PCP and to 3 mM Ba
2+, a Kir channel blocker. Middle, in an oocyte injected with Kir1.1 
mRNA, current responses to 100 μM PCP and to 3 mM Ba
2+. Bottom, in an uninjected oocyte, no significant current responses to 100 μM 
PCP or 3 mM Ba
2+. Asterisks show the zero current level. Bars show the duration of application. (B) Concentration-dependent inhibition of 
GIRK channels by PCP. The magnitudes of inhibition of GIRK currents by PCP were compared with the current components sensitive to 3 
mM Ba
2+. 246    Current Neuropharmacology, 2011, Vol. 9, No. 1  Kobayashi et al. 
concentrations [17, 18]. Furthermore, the concentrations in 
the brain were reported to be from 3 to 14-fold higher than 
those in serum [19]. Additionally, because the early phase 
elimination rate after administration of PCP is relatively high 
[19], the peak concentrations would be higher than the con-
centrations measured. Therefore, the PCP concentrations 
effective in inhibiting GIRK channels overlap the clinically 
relevant brain concentrations in severe intoxication or fatal 
cases. 
 
 
 
 
 
 
 
 
 
Fig. (2). Comparison of the effects of five addictive drugs: PCP, 
cocaine, methylphenidate (MPH), methamphetamine (MAP) and 
MDMA, on GIRK channels. Drug concentration was 100 μM. The 
magnitudes of inhibition of GIRK currents by the drugs were com-
pared with the 3 mM Ba
2+-sensitive current components. Data ex-
cept for PCP are from our previous study [12]. 
  PCP concentrations in severe intoxication cases are asso-
ciated with coma, seizures, muscle rigidity, and respiratory 
arrest [20]. GIRK2 knockout mice show spontaneous sei-
zures and are more susceptible to seizures induced by penty-
lenetetrazol than wild type mice [21]. Furthermore, GIRK 
inhibitors can depolarize the membrane potential and induce 
action potentials [22]. Because GIRK channels play an im-
portant role in regulating cell excitability, even partial inhibi-
tion of neuronal GIRK channels by PCP might contribute to 
the incidence of seizures and some of neuropsychiatric com-
plications observed in severe or fatal cases after overdose. 
GIRK channels may be considered as important molecules 
mediating the effects of PCP, cocaine, opioids, cannabinoids, 
and ethanol among addictive drugs. 
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